It has been more than twenty years since the first Reglan tardive dyskinesia lawsuit was filed, and new lawsuits continue to be brought against the drugs manufacturers.

Reglan, which is also known as generic metrocrlopramide, is a drug approved for the short-term treatment of gastrointestinal disorders. Designed for temporary treatment of diabetic gastroparesis, gastroesophageal reflux (GERD) and delayed gastric emptying, but the dug is often prescribed for longer periods of time. Long-term use of the drug has been shown to greatly increase the risk of tardive dyskinesia in patients.

Tardive dyskinesia is a neurological movement disorder. The disorder causes repetitive and involuntary movement of the face and extremities. Involuntary grimacing, chewing, smacking or pursing of the lips, rapid eye movements and impaired finger movements are common manifestations of the disorder.

If you or a loved one has become ill after use Reglan, contact the Reglan lawsuit attorney of Williams Kherkher by calling 800-761-3187.